找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Adjuvant Therapy of Primary Breast Cancer; Hans-J?rg Senn,Aron Goldhirsch,Bruno Osterwalder Conference proceedings 1989 Springer-Verlag Be

[復(fù)制鏈接]
查看: 54287|回復(fù): 60
樓主
發(fā)表于 2025-3-21 19:24:22 | 只看該作者 |倒序瀏覽 |閱讀模式
期刊全稱Adjuvant Therapy of Primary Breast Cancer
影響因子2023Hans-J?rg Senn,Aron Goldhirsch,Bruno Osterwalder
視頻videohttp://file.papertrans.cn/145/144982/144982.mp4
學(xué)科分類Recent Results in Cancer Research
圖書封面Titlebook: Adjuvant Therapy of Primary Breast Cancer;  Hans-J?rg Senn,Aron Goldhirsch,Bruno Osterwalder Conference proceedings 1989 Springer-Verlag Be
影響因子The ultimate "consumer" of the data presented at conferences on the primary treatment of operable breast cancer is the patient, and when, as in this disease, the benefits of therapy are relatively mod- est, the availability and interpretation of the data from trials be- comes an issue of primary importance. The effects of present treat- ment are in fact such that more patients relapse despite therapy than are estimated to benefit from it. It is, therefore, extremely dif- ficult for the physician to recommend unequivocally one particular adjuvant treatment modality for the vast population of women with breast cancer. The interpretation of results from clinical research-oriented pro- grams is constantly applied, however, in the treatment of breast cancer patients outside of clinical trials. From presented or publish- ed data, many physicians extrapolate indications for the use of a given treatment regimen for their patients, perceiving it as the "best available therapy. " It is essential that the "best available therapy" be selected individually for each patient. However, considering the modest effect of treatment upon outcome, it is imperative that those who provide the data - those
Pindex Conference proceedings 1989
The information of publication is updating

書目名稱Adjuvant Therapy of Primary Breast Cancer影響因子(影響力)




書目名稱Adjuvant Therapy of Primary Breast Cancer影響因子(影響力)學(xué)科排名




書目名稱Adjuvant Therapy of Primary Breast Cancer網(wǎng)絡(luò)公開度




書目名稱Adjuvant Therapy of Primary Breast Cancer網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Adjuvant Therapy of Primary Breast Cancer被引頻次




書目名稱Adjuvant Therapy of Primary Breast Cancer被引頻次學(xué)科排名




書目名稱Adjuvant Therapy of Primary Breast Cancer年度引用




書目名稱Adjuvant Therapy of Primary Breast Cancer年度引用學(xué)科排名




書目名稱Adjuvant Therapy of Primary Breast Cancer讀者反饋




書目名稱Adjuvant Therapy of Primary Breast Cancer讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 23:31:28 | 只看該作者
板凳
發(fā)表于 2025-3-22 01:33:33 | 只看該作者
地板
發(fā)表于 2025-3-22 08:37:40 | 只看該作者
Inference for Location Parameter,an enormous capacity to develop variant phenotypes which display altered degrees of drug sensitivity. (Goldie and Coldman 1984; Von Hoff 1985). Evidence is accumulating that many of the mechanisms of specific drug resistance that have been identified in experimental systems are also likely to occur in clinical situations (Fojo et al. 1987).
5#
發(fā)表于 2025-3-22 11:23:12 | 只看該作者
Dirichlet and Polya tree process,ses, the thinking has changed to that of a two-component disease: local on the one hand, and generalized on the other, the latter being more critical the larger the tumor size, the faster the tumor growth rate, the greater the lymph node involvement, and the less the differentiation on histological or nuclear grading.
6#
發(fā)表于 2025-3-22 13:51:43 | 只看該作者
7#
發(fā)表于 2025-3-22 18:27:15 | 只看該作者
8#
發(fā)表于 2025-3-22 22:03:54 | 只看該作者
9#
發(fā)表于 2025-3-23 03:42:31 | 只看該作者
https://doi.org/10.1007/978-3-642-83337-3adjuvant therapy; breast cancer; cancer; clinical trial; mortality; oncology; radiotherapy; Radiaton Oncolo
10#
發(fā)表于 2025-3-23 06:14:46 | 只看該作者
978-3-642-83339-7Springer-Verlag Berlin Heidelberg 1989
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 10:16
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
南投市| 璧山县| 浪卡子县| 武邑县| 盱眙县| 满城县| 雷波县| 拜泉县| 镇康县| 台东市| 满洲里市| 九龙县| 岫岩| 石河子市| 清水河县| 黄浦区| 九龙城区| 唐山市| 贺兰县| 和政县| 红河县| 曲周县| 三穗县| 金溪县| 泌阳县| 石门县| 海安县| 北票市| 佛坪县| 含山县| 南城县| 陕西省| 林州市| 桐庐县| 马尔康县| 桦川县| 南木林县| 辉南县| 乳山市| 荣昌县| 彭山县|